ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
0.00%
US Dollar vs AUD
1.53421
0.00%
Bitcoin
96,381.03
-0.06%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. CRISPR Therapeutics AG (CRSP)

  7. CRISPR Therapeutics AG (CRSP) News

CRSP

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRSP
DateTimeSourceHeadlineSymbolCompany
15/11/202400:30GlobeNewswire Inc.CRISPR Therapeutics to Present at the Jefferies London Healthcare ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
14/11/202409:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
08/11/202400:00GlobeNewswire Inc.CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNASDAQ:CRSPCRISPR Therapeutics AG
06/11/202401:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
06/11/202401:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
06/11/202401:01GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
19/10/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
19/10/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
19/10/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
19/10/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
19/10/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
16/10/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
16/10/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
13/08/202408:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
06/08/202407:22Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:CRSPCRISPR Therapeutics AG
06/08/202406:54Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRSPCRISPR Therapeutics AG
06/08/202406:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRSPCRISPR Therapeutics AG
06/08/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
06/08/202406:01GlobeNewswire Inc.CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:CRSPCRISPR Therapeutics AG
03/06/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
01/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
01/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
01/06/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
31/05/202406:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
30/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
29/05/202422:00GlobeNewswire Inc.CRISPR Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CRSPCRISPR Therapeutics AG
25/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
24/05/202406:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRSPCRISPR Therapeutics AG
23/05/202422:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRSPCRISPR Therapeutics AG
23/05/202422:00GlobeNewswire Inc.CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsNASDAQ:CRSPCRISPR Therapeutics AG
 Showing the most relevant articles for your search:NASDAQ:CRSP

Your Recent History

NYSE
JPM
JP Morgan Chase
ASX
AMP
AMP
COIN
AVAXUSD
Avalanche
NYSE
DIS
Walt Disney
FX
AUDJPY
AUD vs Yen
ASX
FMG
Fortescue
NASDAQ
GOOGL
Alphabet
ASX
QBE
QBE Insurance
FX
AUDUSD
AUD vs US Dollar
ASX
XTO
S&P ASX 100
NYSE
NKE
Nike
ASX
XAO
Australian SE All Ordina...
ASX
XMM
S&P ASX 300 Metals and M...
COIN
ADAUSD
Cardano
NASDAQ
TSLA
Tesla
ASX
WPL
Woodside Petroleum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36